Literature DB >> 22810448

The darker side of randomized trials: recruitment challenges.

Tarek Sibai1, Hope Carlisle, Paul Tornetta.   

Abstract

Randomized trials are thought to provide optimal evidence if carried out correctly. Their application to important questions is the best guide to clinical decision-making. However, these trials are expensive to complete and have a variety of challenges in design and application. This article will review some of the factors that affect our ability to recruit patients into randomized controlled trials for conditions that may be treated surgically by different methods or for conditions for which both nonsurgical and surgical treatments exist.

Entities:  

Mesh:

Year:  2012        PMID: 22810448     DOI: 10.2106/JBJS.L.00240

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  14 in total

1.  Prostate capsule sparing versus nerve sparing radical cystectomy for bladder cancer: results of a randomized, controlled trial.

Authors:  Bruce L Jacobs; Stephanie Daignault; Cheryl T Lee; Khaled S Hafez; Jeffrey S Montgomery; James E Montie; Jean E Humrich; Brent K Hollenbeck; David P Wood; Alon Z Weizer
Journal:  J Urol       Date:  2014-07-24       Impact factor: 7.450

2.  How to optimize participant retention and complete follow-up in surgical research.

Authors:  Manrajr Kaur; Sheila Sprague; Teegan Ignacy; Achilles Thoma; Mohit Bhandari; Forough Farrokhyar
Journal:  Can J Surg       Date:  2014-12       Impact factor: 2.089

3.  Has the Level of Evidence of Podium Presentations at the Musculoskeletal Tumor Society Annual Meeting Changed Over Time?

Authors:  Daniel M Lerman; Matthew G Cable; Patrick Thornley; Nathan Evaniew; Gerard P Slobogean; Mohit Bhandari; John H Healey; R Lor Randall; Michelle Ghert
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

4.  The (in)stability of 21st century orthopedic patient contact information and its implications on clinical research: A cross-sectional study.

Authors:  Daniel A London; Jeffrey G Stepan; Charles A Goldfarb; Martin I Boyer; Ryan P Calfee
Journal:  Clin Trials       Date:  2016-11-30       Impact factor: 2.486

5.  ClinicalTrials.gov as a data source for semi-automated point-of-care trial eligibility screening.

Authors:  Pascal B Pfiffner; JiWon Oh; Timothy A Miller; Kenneth D Mandl
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

6.  An approach for transgender population information extraction and summarization from clinical trial text.

Authors:  Boyu Chen; Hao Jin; Zhiwen Yang; Yingying Qu; Heng Weng; Tianyong Hao
Journal:  BMC Med Inform Decis Mak       Date:  2019-04-09       Impact factor: 2.796

7.  Which orthopaedic trauma patients are likely to refuse to participate in a clinical trial? A latent class analysis.

Authors:  Nathan N O'Hara; Yasmin Degani; Debra Marvel; David Wells; C Daniel Mullins; Stephen Wegener; Katherine Frey; Tara Joseph; Jonathan Hurst; Renan Castillo; Robert V O'Toole
Journal:  BMJ Open       Date:  2019-10-11       Impact factor: 2.692

8.  The impact of surgeon and patient treatment preferences in an orthopaedic trauma surgery trial.

Authors:  Ada Keding; Helen Handoll; Stephen Brealey; Laura Jefferson; Catherine Hewitt; Belen Corbacho; David Torgerson; Amar Rangan
Journal:  Trials       Date:  2019-09-18       Impact factor: 2.279

9.  Will they participate? Predicting patients' response to clinical trial invitations in a pediatric emergency department.

Authors:  Yizhao Ni; Andrew F Beck; Regina Taylor; Jenna Dyas; Imre Solti; Jacqueline Grupp-Phelan; Judith W Dexheimer
Journal:  J Am Med Inform Assoc       Date:  2016-04-27       Impact factor: 4.497

10.  Factors influencing the enrollment in randomized controlled trials in orthopedics.

Authors:  Christopher T Lim; Heather J Roberts; Jamie E Collins; Elena Losina; Jeffrey N Katz
Journal:  Contemp Clin Trials Commun       Date:  2017-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.